Diagnostic management of chronic obstructive pulmonary disease

Netherlands Journal of Medicine

Volumn 70, Issue 1, 2012, Pages 6-11

  Broekhuizen, B D L ^a   Sachs, A P E ^a   Hoes, A W ^a   Verheij, T J M ^a   Moons, K G M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CoPd; Diagnosis; History taking; Physical examination; Spirometry

Indexed keywords

AIRWAY OBSTRUCTION; ASTHMA; BIRTH WEIGHT; BODY PLETHYSMOGRAPHY; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DYSPNEA; FAMILY HISTORY; FORCED VITAL CAPACITY; HUMAN; INFLAMMATION; LUNG AUSCULTATION; LUNG FUNCTION TEST; MEDICAL HISTORY; OCCUPATIONAL HAZARD; PHLEGMON; PHYSICAL EXAMINATION; RESIDUAL VOLUME; REVIEW; SMOKING HABIT; SPIROMETRY; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; WHEEZING;

BRONCHODILATOR AGENTS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; MEDICAL HISTORY TAKING; PHYSICAL ENDURANCE; PLETHYSMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SPIROMETRY; TIME FACTORS; VITAL CAPACITY;

EID: 84856325766     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-55.
2. Miller CE, Jones SF, Bailey WC, Dransfeld MT. Underdiagnosis of COPD in the national lung screening trial. Chest. 2006;130(4):280S-280d.
3. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402-7.
4. Hoogendoorn M, Feenstra TL, Schermer TR, Hesselink AE, Rutten-van Molken MP. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Respir Med. 2006;100(1):83-6.
5. Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, Small I. Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. Prim Care Respir J. 2009;18(3):130-47.
6. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;147(9):633-8.
7. Smeele IJM, van Weel C, Van Schayck CP, Van der Molen T, Thoonen B, Schermer TR, et al. NHG-standaard COPD. Huisarts en Wetenschap. 2007;50(8):362-79.
8. Fletcher C, Peto R. The natural history of chronic airfow obstruction. Br Med J. 1977;1(6077):1645-8.
9. Kohansal R, Martinez-Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The Natural History of Chronic Airfow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort. Am J Respir Crit Care Med. 2009;180(1):3-10.
10. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733-43.
11. Straus SE, McAlister FA, Sackett DL, Deeks JJ. The accuracy of patient history, wheezing, and laryngeal measurements in diagnosing obstructive airway disease. CARE-COAD1 Group. Clinical Assessment of the Reliability of the Examination-Chronic Obstructive Airways Disease. JAMA. 2000;283(14):1853-7.
12. Badgett RG, Tanaka DJ, Hunt DK, Jelley MJ, Feinberg LE, Steiner JF, et al. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical fndings alone? Am J Med. 1993;94(2):188-96.
13. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721-32.
14. Holleman DR, Simel DL. Does the clinical examination predict airfow limitation? JAMA. 1995;273(4):313-9.
15. Thiadens HA, de Bock GH, Dekker FW, Huysman JA, van Houwelingen JC, Springer MP, et al. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study. BMJ. 1998;316(7140):1286-90.
16. Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case fnding study. BMJ. 2002;324(7350):1370-4.
17. Buffels J, Degryse J, Heyrman J, Decramer M. Offce spirometry signifcantly improves early detection of COPD in general practice: the DIDASCO Study. Chest. 2004;125(4):1394-9.
18. Demedts M. Mechanisms and consequences of hyperinfation. Eur Respir J. 1990;3(6):617-8.
19. Broekhuizen BD, Sachs AP, Oostvogels R, Hoes AW, Verheij TJ, Moons KG. The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review. Fam Pract. 2009;26(4):260-8.
20. Garcia-Pachon E. Paradoxical movement of the lateral rib margin (Hoover sign) for detecting obstructive airway disease. Chest. 2002;122(2):651-5.
21. Badgett RG, Tanaka DJ, Hunt DK, Jelley MJ, Feinberg LE, Steiner JF, et al. The clinical evaluation for diagnosing obstructive airways disease in high-risk patients. Chest. 1994;106(5):1427-31.
22. Holleman DR, Simel DL, Goldberg JS. Diagnosis of obstructive airways disease from the clinical examination. J Gen Intern Med. 1993;8(2):63-8.
23. Straus SE, McAlister FA, Sackett DL, Deeks JJ. Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease. J Gen Intern Med. 2002;17(9):684-8.
24. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856-61.
25. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two. Am J Respir Care Med. 1994;150(4):1158-68.
26. Schapira RM, Schapira MM, Funahashi A, McAuliffe TL, Varkey B. The value of the forced expiratory time in the physical diagnosis of obstructive airways disease. JAMA. 1993;270(6):731-6.
27. Schermer TR, Jacobs JE, Chavannes NH, Hartman J, Folgering HT, Bottema BJ, et al. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax. 2003;58(10):861-6.
28. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassifcation of airway obstruction. Thorax. 2008;63(12):1046-51.
29. Roberts SD, Farber MO, Knox KS, Phillips GS, Bhatt NY, Mastronarde JG, et al. FEV1/FVC ratio of 70% misclassifes patients with obstruction at the extremes of age. Chest. 2006;130(1):200-6.
30. Brusasco VF, Crapo RF, Viegi G. Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J. 2005;26(1):1-2.
31. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory fows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Offcial Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5-40.
32. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179-87.
33. Kapp MC, Schachter EN, Beck GJ, Maunder LR, Witek TJ. The shape of the maximum expiratory fow volume curve. Chest. 1988;94(4):799-806.
34. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis. 1981;123:185-9.
35. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-68.
36. Boulet LP, Turcotte HF, Hudon CF, Carrier GF, Maltais F. Clinical, physiological and radiological features of asthma with incomplete reversibility of airfow obstruction compared with those of COPD. Can Respir J. 1998;5:270-7.
37. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 60 A.D.;144(5):1202-1218.
38. Beasley R, Weatherall M, Travers J, Shirtcliffe P. Time to defne the disorders of the syndrome of COPD. Lancet. 2009;374(9691):670-2.
39. Gross NJ. COPD: a disease of reversible air-fow obstruction. Am Rev Respir Dis. 1986;133(5):725-6.
40. Nisar M, Walshaw M, Earis JE, Pearson MG, Calverley PM. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax. 1990;45(3):190-4.
41. Broekhuizen BDL, Sachs APE, Moons KGM, Cheragwandi SAA, Damste HEJS, Wijnands GJA, et al. Diagnostic Value of Oral Prednisolone Test for Chronic Obstructive Pulmonary Disorders. Ann Fam Med. 2011;9(2):104-9.
42. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). Available from: http://wwwginasthmaorg 2011.
43. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728-35.
44. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration. 2006;73(3):296-305.
45. Karadag F, Kirdar S, Karul AB, Ceylan E. The value of C-reactive protein as a marker of systemic infammation in stable chronic obstructive pulmonary disease. Eur J Intern Med. 2008;19(2):104-8.
46. Gan WQ, Man SF, Senthilselvan AF, Sin DD. Association between chronic obstructive pulmonary disease and systemic infammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574-80.
47. Geijer RM, Sachs AP, Hoes AW, Salome PL, Lammers JW, Verheij TJ. Prevalence of undetected persistent airfow obstruction in male smokers 40-65 years old. Fam Pract. 2005;22(5):485-9.
48. Broekhuizen BD, Sachs AP, Hoes AW, Moons KG, van den Berg JW, Dalinghaus WH, et al. Undetected chronic obstructive pulmonary disease and asthma in people over 50 years with persistent cough. Br J Gen Pract. 2010;60(576):489-94.
49. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-6.
50. Van Der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1(1):13.
51. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail. 2006;8(7):706-11.
52. Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax. 2006;61(10):869-73.
53. Parkes G, Greenhalgh T, Griffn M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008;336(7644):598-600.